Vascular safety of erenumab for migraine prevention

OBJECTIVE: To examine the cardiovascular, cerebrovascular, and peripheral vascular safety of erenumab across migraine prevention studies. METHODS: Vascular adverse events (AEs) and blood pressure data were integrated across 4 double-blind, placebo-controlled studies of erenumab and their open-label...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudrow, David, Pascual, Julio, Winner, Paul K., Dodick, David W., Tepper, Stewart J., Reuter, Uwe, Hong, Frank, Klatt, Jan, Zhang, Feng, Cheng, Sunfa, Picard, Hernan, Eisele, Osa, Wang, Julie, Latham, Jonathan N., Mikol, Daniel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080286/
https://www.ncbi.nlm.nih.gov/pubmed/31852816
http://dx.doi.org/10.1212/WNL.0000000000008743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080286/
https://www.ncbi.nlm.nih.gov/pubmed/31852816
http://dx.doi.org/10.1212/WNL.0000000000008743

Ejemplares similares